A61P 25 - Drugs for disorders of the nervous system

Patents for A61P 25 - Drugs for disorders of the nervous system (183,225)
12/2004
12/01/2004	EP1480948A1 Semicarbazide derivatives and their use as antithrombotics
12/01/2004	EP1480678A2 Treatment of ophthalmic disorders using urea and urea derivatives
12/01/2004	EP1480674A1 Treatment of central nervous system damage
12/01/2004	EP1480673A1 A bioadhesive agent
12/01/2004	EP1480672A2 Compositions and compounds for use as a nicotine vaccine employing response selective agonist of an antigen-presenting cell receptor as a molecular adjuvant
12/01/2004	EP1480666A2 Immunizing composition and method for inducing an immune response against the ss-secretase cleavage site of amyloid precursor protein
12/01/2004	EP1480647A1 Mono-ester and asymmetrically substituted di-ester pro-drugs of the dopamine d1 receptor agonists
12/01/2004	EP1480643A1 Use of epothilones in the treatment of brain diseases associated with proliferative processes
12/01/2004	EP1480639A1 Combinations of an alpha-2-delta ligand with a selective inhibitor of cyclooxygenase-2
12/01/2004	EP1480632A1 A novel dosage form of l-methionine s-sulfoximine
12/01/2004	EP1480626A1 Ambroxol for treating painful conditions in the mouth and pharyngeal cavity
12/01/2004	EP1480624A2 Pharmaceutical tablet
12/01/2004	EP1480618A1 Sustained release drug formulations containing a carrier peptide
12/01/2004	EP1480616A1 Aerosol formulations for pulmonary administration of medicaments to produce a systemic effect
12/01/2004	EP1480598A2 Manipulation of cytokine levels using cd83 gene products
12/01/2004	EP1480521A2 Myelination of congenitally dysmyelinated forebrains using oligodendrocyte progenitor cells
12/01/2004	EP1435787A4 Nestin-expressing hair follicle stem cells
12/01/2004	EP1412340A4 Process for the preparation of citalopram hydrobromide
12/01/2004	EP1399448B1 Imidazo 1,5-a] pyrimido 5,4-d] benzazepine derivatives as gaba a receptor modulators
12/01/2004	EP1318996B1 Substituted imidazoles as dual histamine h1 and h3 agonists or antagonists
12/01/2004	EP1257584B9 Humanized antibodies that sequester amyloid beta peptide
12/01/2004	EP1246625B1 Uses and compositions of nitrate esters for providing sedation
12/01/2004	EP1189631B1 Neurodegenerative disorder related gene
12/01/2004	EP1183040B1 Therapeutic use of an inhibitor of a hedgehog signalling pathway
12/01/2004	EP1175408B1 Pyrimidinone compounds
12/01/2004	EP1119538B1 Derivatives of phenantrene for medicinal use and a process for their preparation
12/01/2004	EP1075264B1 New drug combinations of reboxetine and pindolol
12/01/2004	EP1056462A4 Use of rhamnolipids in wound healing, treating burn shock, atherosclerosis, organ transplants, depression, schizophrenia and cosmetics
12/01/2004	EP0977745B1 Thioaryl sulfonamide hydroxamic acid compounds
12/01/2004	EP0808316B9 Vasoconstrictive substituted 2,3-dihydro-1,4-dioxinopyridines
12/01/2004	CN1551919A 治疗性结合分子 Therapeutic binding molecules
12/01/2004	CN1551914A FAD4, FAD5, FAD5-2 and FAD6, novel fatty acid desaturase family members and uses thereof
12/01/2004	CN1551882A Novel anticonvulsant derivative salts
12/01/2004	CN1551879A Stable polymorph of FLIBANSERIN, technical process for its preparation and the use thereof for preparing medicaments
12/01/2004	CN1551877A Piperidine derivatives useful as CCR5 antagonists
12/01/2004	CN1551869A Novel compound
12/01/2004	CN1551778A Pharmaceutical composition for diabetic neuropathy
12/01/2004	CN1551770A Sustained release formulations of oxymorphone
12/01/2004	CN1551769A Substituted 8-arylquinoline phosphodiesterase-4 inhibitors
12/01/2004	CN1551766A Lymphocytic activation inhibitor and remedial agent for autoimmune disease
12/01/2004	CN1551762A Valproic acid derivatives for the treatment of pain.
12/01/2004	CN1550496A Acetylenic alpha-amino acid-based sulfamide hydroxamic acid TACE inhibitors
12/01/2004	CN1550491A Novel delta-amino-gamma-hydroxy-omega-aryl-alkanoic acid amides
12/01/2004	CN1177860C Cholenic acid amides and pharmaceutical compositions thereof
12/01/2004	CN1177847C Oxazolidines compounds as 5-HT2A-antagonists
12/01/2004	CN1177831C New benzimidazolone-benzoxazolone-, or benzothiazoloe derivatives as ion channel modulating agents
12/01/2004	CN1177830C Benzoheterocycles and their use as MEK inhibitors
12/01/2004	CN1177828C Novel hydantoin, thiohydantoin, pyrimidinedione and thioxopyrimidinone derivatives, preparation method and use as medicines
12/01/2004	CN1177825C Substituted 1,2,3,4,5,6-hexahydro-2,6-methano-3-benzazocines and the use thereof as medicaments
12/01/2004	CN1177616C Recombinant antibodies specific for beta-amyloid ends, DNA encoding and methods of use thereof
12/01/2004	CN1177609C Medicine for curing sleepless
12/01/2004	CN1177604C Medicine for preventing and treating neurashthenia
12/01/2004	CN1177596C Ginkgo biloba leaf extracts with reduced 4'-0-methypyridoxine and biflavone content
12/01/2004	CN1177589C Analgesic combination
12/01/2004	CN1177587C Riluzole and alpha-tocopherol combination
12/01/2004	CN1177586C Use of pramipexole as nerveprotective agent
11/2004
11/30/2004	US6825349 Purine derivatives for treatment of gastrointestinal disorders, immunological disorders, neurological disorders
11/30/2004	US6825329 Human PEM as a target for birth control and treatment of Alzheimer's disease
11/30/2004	US6825231 Substituted norbornylamino derivatives, processes for their preparation, their use as medicaments or diagnostics, and a medicament comprising them
11/30/2004	US6825229 Administering protein kinase c activators such as macrocyclic lactones (i.e. bryostatin class and neristatin class)
11/30/2004	US6825224 Prodrugs of carbamate inhibitors of IMPDH
11/30/2004	US6825222 Modulators of peroxisome proliferator activated receptors
11/30/2004	US6825221 Arylsulfanyl and heteroarylsulfanyl derivatives for treating pain
11/30/2004	US6825219 Substituted benzimidazole compounds
11/30/2004	US6825217 Heterocyclic amines such as 4-(3'-thienyl)-alpha, alpha, 1-trimethyl-4-piperidinemethanol and/or prodrugs, used as analgesics for prophylaxis of neuropathic pain
11/30/2004	US6825212 1-(aminoalkyl)-3-sulfonylazaindoles as 5-hydroxytryptamine-6 ligands
11/30/2004	US6825203 Topical anesthetic/opioid formulations and uses thereof
11/30/2004	US6825202 Central nervous system disorders; psychological disorders
11/30/2004	US6825200 Substituted dipeptides having nos inhibiting activity
11/30/2004	US6825198 5-HT receptor ligands and uses thereof
11/30/2004	US6825193 Heterocyclic amines such as 4-(3,4-dichlorophenyl)-2-(2-(4-methylpiperazin-1-yl)-benzylidene) -thiomorpholin-3-one, used as antiserotonine agents
11/30/2004	US6825192 Non-n-methyl-d-aspartate (non- nmda) excitatory amino acid receptor antagonistic action, for example 2-amino-3-hydroxy-5-methyl-4-isoxazole propionic acid (ampa) receptor antagonistic action
11/30/2004	US6825190 Protein kinase inhibitors and uses thereof
11/30/2004	US6825189 Treating withdrawal symptoms caused by smoking cessation
11/30/2004	US6825185 Improving the cardiovascular profile of a cox-2 selective inhibitor by administering with 3-hydroxy-3- methylglutaryl coenzyme a, an antiplatelet agent, a thrombin inhibitor or a thromboxane inhibitor
11/30/2004	US6825184 For use as anti-inflammatory agents
11/30/2004	US6824978 Regulation of endogenous gene expression in cells using zinc finger proteins
11/30/2004	CA2524805A1 Use of a compound in the treatment of sleep disorders
11/30/2004	CA2362117C A system for cell-based screening
11/30/2004	CA2298245C Matrix controlled release device
11/30/2004	CA2251795C Novel n-aminoalkyl-1-biphenylenyl-2-carboxamides; new dopamine receptor subtype specific ligands
11/27/2004	CA2464379A1 Use of anti-glaucoma drugs to treat visual defects associated with the use of a gabaergic agent
11/25/2004	WO2004102774A1 Dc motor
11/25/2004	WO2004101787A1 Inhibition of the expression of huntington gene
11/25/2004	WO2004101775A1 Novel stem cell derived from adult tissue and use thereof
11/25/2004	WO2004101603A1 Statine derivatives for the treatment of alzheimer's disease
11/25/2004	WO2004101565A2 Jnk inhibitors
11/25/2004	WO2004101559A1 Fused bicyclic-substituted amines as histamine-3 receptor ligands
11/25/2004	WO2004101558A1 2-imidazo-benzothiazoles as adenosine receptor ligands
11/25/2004	WO2004101529A1 Nitrogenous heterocyclic compound and medical use thereof
11/25/2004	WO2004101522A1 Diarylmethylidene piperidine derivatives, preparations thereof and uses thereof
11/25/2004	WO2004101521A1 Diarylmethylidene piperidine derivatives, preparations thereof and uses thereof
11/25/2004	WO2004101519A1 Diarylmethylidene piperidine derivatives, preparations thereof and uses thereof
11/25/2004	WO2004101518A1 4-arylsulphonylpiperidine derivatives for antagonism of the 5-ht2a receptor
11/25/2004	WO2004101483A1 Novel trisubstituted benzene derivative, process for producing the same and medical drug composition containing the derivative
11/25/2004	WO2004101072A1 Cns chloride modulation and uses thereof
11/25/2004	WO2004100992A2 Therapeutic combinations of atypical antipsychotics with gaba modulators, anticonvulsants or benzodiazapines
11/25/2004	WO2004100972A1 Preventive and/or remedy for diseases accompanied by tissue destruction
11/25/2004	WO2004100959A1 External patch containing estrogen and/or progestogen
11/25/2004	WO2004100958A1 2, 3, 4, 5-tetrahydrobenzo[f][1, 4]oxazepine-5-carboxylic acid amide derivatives as gamma-secretase inhibitors for the treatment of alzheimer’s disease

1 ... 1025 1026 1027 1028 1029 1030 1031 1032 1033 1034 1035 1036 1037 1038 1039 1040 1041 1042 1043 1044 1045 ... 1833